Piwowarczyk, Paweł
Szczukocka, Marta
Cios, Wojciech
Okuńska, Paulina
Raszewski, Grzegorz
Borys, Michał
Wiczling, Paweł http://orcid.org/0000-0002-2878-3161
Czuczwar, Mirosław
Clinical trials referenced in this document:
Documents that mention this clinical trial
Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19
https://doi.org/10.1007/s40262-023-01244-4
Article History
Accepted: 20 March 2023
First Online: 25 April 2023
Declarations
:
: No external funding was used in the preparation of this article.
: Paweł Piwowarczyk, Marta Szczukocka, Wojciech Cios, Paulina Okuńska, Grzegorz Raszewski, Michał Borys, Paweł Wiczling, and Mirosław Czuczwar have no conflicts of interest that are directly relevant to the content of this article.
: The study was approved by the local ethics committee (consent number KE 0254/23/2021) and performed in accordance with the ethical standards of the Helsinki Declaration.
: Oral consent was obtained from each conscious patient. In the case of unconscious patients or mechanically ventilated patients, the consent was waived by the ethics committee.
: Not applicable.
: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: Methodology: PP, PW, MC, MB, MS, WC, PO, GR; formal analysis: PP, PW, MC, MB, MS, WC, PO, GR; investigation, data curation: PP, PW, MC, MB, MS, WC, PO, GR; writing: original draft preparation: PP, PW, MC, MB, MS, WC, PO, GR; writing: review and editing: PP, PW, MC, MB, MS, WC, PO, GR; supervision: MC; project administration: PP. All authors have read and agreed to the published version of the manuscript and to be accountable for all aspects of the work.